Pfizer's Torisel drug fails in a combination study
Fri, Aug 10 08:23 AM EDT
(Reuters) - Pfizer Inc said on Friday that a late-stage trial of its drug for renal cell cancer failed to meet its main goal when given in combination with Avastin, a drug made by Roche Holding AG.
